![Mel Hayes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mel Hayes
Corporate Officer/Principal bei FULCRUM THERAPEUTICS, INC.
Vermögen: 52 422 $ am 31.05.2024
Aktive Positionen von Mel Hayes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FULCRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 02.10.2023 | - |
Geschäftsführer | 09.08.2022 | 02.10.2023 |
Karriereverlauf von Mel Hayes
Ehemalige bekannte Positionen von Mel Hayes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BAXALTA INC | Corporate Officer/Principal | - | - |
Shire, Inc.
![]() Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Vertrieb & Marketing | - | - |
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - | - |
BIOVERATIV INC | Corporate Officer/Principal | - | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Mel Hayes
Southern Methodist University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Corporate Officer/Principal | 5 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FULCRUM THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Bioverativ, Inc.
![]() Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
Shire, Inc.
![]() Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Health Technology |
Baxalta, Inc.
![]() Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |